Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.
Tacconi EM, Badie S, De Gregoriis G, Reisländer T, Lai X, Porru M, Folio C, Moore J, Kopp A, Baguña Torres J, Sneddon D, Green M, Dedic S, Lee JW, Batra AS, Rueda OM, Bruna A, Leonetti C, Caldas C, Cornelissen B, Brino L, Ryan A, Biroccio A, Tarsounas M. Tacconi EM, et al. Among authors: cornelissen b. EMBO Mol Med. 2019 Jul;11(7):e9982. doi: 10.15252/emmm.201809982. Epub 2019 May 24. EMBO Mol Med. 2019. PMID: 31273933 Free PMC article.
Immuno-imaging of ICAM-1 in tumours by SPECT.
Mosley M, Baguña Torres J, Allen D, Cornelissen B. Mosley M, et al. Among authors: cornelissen b. Nucl Med Biol. 2020 May-Jun;84-85:73-79. doi: 10.1016/j.nucmedbio.2020.02.014. Epub 2020 Feb 25. Nucl Med Biol. 2020. PMID: 32135474 Free PMC article.
Emerging chelators for nuclear imaging.
Sneddon D, Cornelissen B. Sneddon D, et al. Among authors: cornelissen b. Curr Opin Chem Biol. 2021 Aug;63:152-162. doi: 10.1016/j.cbpa.2021.03.001. Epub 2021 May 26. Curr Opin Chem Biol. 2021. PMID: 34051509 Review.
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma.
Chan CY, Hopkins SL, Guibbal F, Pacelli A, Baguña Torres J, Mosley M, Lau D, Isenegger P, Chen Z, Wilson TC, Dias G, Hueting R, Gouverneur V, Cornelissen B. Chan CY, et al. Among authors: cornelissen b. EJNMMI Res. 2022 Oct 9;12(1):67. doi: 10.1186/s13550-022-00940-9. EJNMMI Res. 2022. PMID: 36210377 Free PMC article.
PARP Inhibitors in Cancer Diagnosis and Therapy.
Chan CY, Tan KV, Cornelissen B. Chan CY, et al. Among authors: cornelissen b. Clin Cancer Res. 2021 Mar 15;27(6):1585-1594. doi: 10.1158/1078-0432.CCR-20-2766. Epub 2020 Oct 20. Clin Cancer Res. 2021. PMID: 33082213 Review.
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.
Li D, Bentley C, Anderson A, Wiblin S, Cleary KLS, Koustoulidou S, Hassanali T, Yates J, Greig J, Nordkamp MO, Trenevska I, Ternette N, Kessler BM, Cornelissen B, Cragg MS, Banham AH. Li D, et al. Among authors: cornelissen b. Cancer Res. 2017 May 15;77(10):2699-2711. doi: 10.1158/0008-5472.CAN-16-3247. Epub 2017 Mar 31. Cancer Res. 2017. PMID: 28363997
PET Imaging of PARP Expression Using 18F-Olaparib.
Wilson TC, Xavier MA, Knight J, Verhoog S, Torres JB, Mosley M, Hopkins SL, Wallington S, Allen PD, Kersemans V, Hueting R, Smart S, Gouverneur V, Cornelissen B. Wilson TC, et al. Among authors: cornelissen b. J Nucl Med. 2019 Apr;60(4):504-510. doi: 10.2967/jnumed.118.213223. Epub 2018 Nov 2. J Nucl Med. 2019. PMID: 30389822 Free PMC article.
219 results